Garopride 50 Mg 30 Tablets

Garopride 50 mg 30 Tablets

Description:

Garopride 50 mg 30 Tablets is a prescription oral medication containing itopride, a prokinetic motility stimulant from EVA Pharma. It is used to enhance gastrointestinal motility and relieve symptoms associated with functional dyspepsia and delayed gastric emptying. As a dopamine (D2) receptor antagonist and acetylcholinesterase inhibitor, Garopride improves gastric emptying, increases esophageal and gastrointestinal peristalsis, and helps reduce nausea, bloating, and early satiety. It is intended for adult use under medical supervision.

Indications:

• Functional dyspepsia (non-ulcer dyspepsia) associated with delayed gastric emptying.
• Gastrointestinal motility disorders such as postprandial fullness, upper abdominal discomfort, and early satiety.
• Symptoms related to gastroesophageal reflux and impaired esophageal motility (e.g., heartburn, regurgitation) as adjunct therapy as directed by a physician.
• Nausea and vomiting related to impaired gastric motility, as prescribed by a doctor.
• Bloating, abdominal distension, and discomfort due to reduced gastric and intestinal peristalsis.

Active Ingredients / Key Components:

• Itopride hydrochloride – 50 mg per film-coated tablet.
• Excipients (tablet core and coating) – exact composition and concentrations are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); please refer to the package insert for full excipient list.

Dosage & Administration / How to Use:

• Adults (oral): Typical dosage is 50 mg (1 tablet) three times daily.
• Tablets should be taken before meals (usually about 30 minutes prior) to maximize prokinetic effect on gastric emptying.
• Swallow the tablet whole with a sufficient amount of water; do not crush or chew unless advised by your doctor.
• Duration of treatment should be determined by the prescribing physician based on the patient’s condition and response to therapy.
• Do not exceed the prescribed dose or frequency. If a dose is missed, take it as soon as you remember unless it is almost time for the next dose; do not double the dose.
• Use in children and adolescents should only be under strict medical supervision, if at all, as safety and dosing are not well established.
• Patients with renal or hepatic impairment may require dose adjustment; follow your doctor’s instructions carefully.

Clinical Benefits:

• Enhances gastric motility and accelerates gastric emptying, helping relieve postprandial fullness and abdominal discomfort.
• Increases esophageal and gastrointestinal peristalsis and lower esophageal sphincter pressure, which may help reduce reflux-related symptoms.
• Improves gastro-duodenal coordination, supporting more efficient digestion and transit of food.
• Provides anti-emetic action through dopamine D2 receptor antagonism at the chemoreceptor trigger zone (CTZ), helping reduce nausea and vomiting associated with motility disorders.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity or allergy to itopride or any of the tablet components.
• Contraindicated in patients with gastrointestinal bleeding, mechanical obstruction, or perforation where increased motility could be harmful.
• Use with caution in patients with severe hepatic or renal impairment; dose adjustment or close monitoring may be required.
• May interact with other motility agents such as cisapride and anticholinergic drugs like atropine; concomitant use should be evaluated by a physician.
• Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding; safety data in pregnancy and lactation are limited.
• Use with caution in elderly patients who may be more sensitive to side effects or have multiple comorbidities and medications.
• If you experience severe abdominal pain, persistent vomiting, blood in stool or vomit, chest pain, or signs of allergic reaction (rash, swelling, difficulty breathing), stop the medication and seek immediate medical attention.
• Consult your doctor before use if you have liver disease, kidney disease, gastrointestinal ulcers, or a history of severe drug reactions.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include abdominal pain or discomfort, diarrhea, constipation, dry mouth, headache, dizziness, or increased salivation.
• Less common side effects can include rash, pruritus, or other allergic skin reactions.
• Rarely, changes in liver function tests, jaundice, or severe hypersensitivity reactions may occur; discontinue use and contact your doctor immediately if such symptoms appear.
• If you experience persistent or severe side effects, or any unusual symptoms, stop taking the medication and seek medical advice promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature recommended on the package insert (specific temperature range is not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).

Specifications:

• Product form: Film-coated tablets.
• Strength: 50 mg itopride hydrochloride per tablet.
• Pack size: 30 tablets per pack.
• Intended use: Prescription gastrointestinal motility stimulant for adults, as directed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.